Vilon Peptide — Research Profile & Overview
The vilon peptide is a dipeptide bioregulator composed of just two amino acids — lysine and glutamic acid (lysylglutamic acid) — making it one of the simplest peptide bioregulators studied in modern longevity research. First characterized by researchers at the St. Petersburg Institute of Bioregulation and Gerontology, vilon has been extensively studied for its influence on gene expression, immune function, and cellular integrity in laboratory models. This page provides a strictly research-oriented overview of current scientific findings.
What Is Vilon? Peptide Vilon Overview
Vilon is a synthetic dipeptide consisting of lysine and glutamic acid. In its research form, it is classified among the short peptides known as peptide bioregulators — compounds that appear to modulate protein synthesis and gene-level activity in specific tissues. Laboratory research suggests vilon interacts with chromatin structures and may influence the transcription of ribosomal genes, offering a window into fundamental mechanisms of aging and immune balance.
The compound has been investigated primarily in animal models and in vitro cell culture systems, including thymic cell cultures and cultured lymphocytes. Research suggests that vilon may support tissue regeneration and balanced immune function through its effects at the molecular level. Available for research from Iron Peak Peptides.
Lysylglutamic Acid: The Chemistry of Vilon
As lysylglutamic acid, vilon is composed of two amino acids: L-lysine and L-glutamic acid joined by a standard peptide bond. This minimalist structure means the compound can potentially diffuse through cell nuclei and interact directly with chromatin — including both euchromatic regions and pericentromeric structural heterochromatin. The dipeptide’s small size has made it a valuable tool in studies examining induced reactivation of chromatin in aged tissue systems.
Published studies in Bull Exp Biol Med and Georgian Med News (Khavinson VKh, Lezhava T, Jokhadze T, Monaselidze J) have explored how this compound modulates nucleolus organizer regions and total heterochromatin levels in animal and human cell preparations, providing early molecular-level insights into its potential role in aging research.
Gene Expression and Vilon Research
A significant portion of vilon research has focused on its effects on gene expression in lymphocytes and thymic cells. Laboratory research using thymic lobules and lymphocyte precursors showed that the bioregulator vilon induced reactivation of chromatin in cultured lymphocytes from old organisms — suggesting that vilon appears to reverse age-associated chromatin compaction, thereby supporting ribosomal RNA synthesis and transcriptionally active regions.
The bioregulator vilon induced reactivation of decondensing nucleolus organizer regions and facultative heterochromatin in studies by Khavinson and colleagues. These gene expression changes were associated with increased proliferative activity in aging cell populations — a finding that has generated ongoing scientific interest in vilon as a research model for longevity research.
Immune System Modulation and Immune Cell Proliferation
Vilon’s immunomodulating effects have been studied extensively in laboratory settings. Research findings in cultured lymphocytes show that the peptide can support T cell differentiation and promote progressive activation of lymphocyte precursors. In thymic cell cultures derived from mature t helper cells, vilon appeared to modulate immune response by restoring balanced immune function in aged immune cells.
In experimental models involving mice, vilon was observed to support immune cell proliferation and strengthen immune balance without inducing excessive inflammatory processes. The peptide’s influence on immune cells appears mediated through its effects on chromatin structure and ribosomal genes — regulatory mechanisms that control the body’s natural repair processes and protein synthesis rates.
Cultured Lymphocytes: Key Research Models
Much of the foundational vilon research relied on cultured lymphocytes from old people as the primary cellular model. These ex vivo cell preparations allowed researchers to observe vilon’s effects on cellular integrity, proliferation, and chromatin state without confounding variables from whole-organism studies. Results showed that chromatin in cultured lymphocytes from aged donors was significantly more condensed and transcriptionally suppressed compared to young donor cells — and that vilon treatment could partially reverse this age-associated compaction.
Secondary research extended to thymic cell cultures, including cultures from thymic lobules, where vilon demonstrated its ability to induce decondensation of chromatin structures and upregulate markers associated with immune support. Control group comparisons consistently highlighted the peptide appeared to normalize cellular chromatin architecture in these experimental models.
Healthy Aging and Longevity Research
The anti aging effects of vilon have been explored in several animal studies. Research involving spontaneous tumors in laboratory models suggested that vilon treatment was associated with a reduction in early neoplastic changes in the urinary bladder mucosa and duodenal mucosa — tissues within the gastrointestinal tract where age-related cellular changes are well documented. These findings positioned vilon as a research compound of interest in longevity research, particularly for studying mechanisms by which short peptides might counteract cellular aging.
The peptide’s influence on lifespan has also been studied using experimental models focused on angiogenesis, immune regulation, and stem cell activity. Research suggests vilon may optimize cellular regulation and promote recovery from accumulated molecular damage — key aspects of the healthy aging process that continue to be investigated in national center and biotechnology information databases.
Vilon and Anti Aging Effects in Laboratory Models
Among the anti aging peptides studied in bioregulator research, vilon stands out due to its simplicity and breadth of observed effects. The peptide vilon has been linked to reduced proliferative index decline in critical tissues, improved cellular integrity markers in bladder cancer models, and enhanced recovery in laboratory models subjected to radiation. These profound effects across different cell types have made it a widely referenced compound in the peptide bioregulators literature.
Research also suggests vilon may protect against infections and pathogens through immunomodulating effects, and that its influence on stem cells supports tissue regeneration in aging animal systems. These laboratory observations make it an increasingly studied research model — though extensive human data remains limited at this time.
Tissue Repair and Regeneration Research
Beyond its immune-focused applications, vilon has been investigated for tissue repair and tissue regeneration capacity in various organ systems. Researchers have examined its effects in bladder tissue, thymic tissue, duodenal mucosa, and other critical tissues where the body’s natural repair processes decline with age. Studies in young and old animal models found that vilon treatment was associated with improved recovery metrics and reduced markers of cellular degradation.
The peptide’s ability to upregulate synthetic processes and promote production of regulatory proteins at the genetic level makes it a compelling research subject for scientists studying the molecular foundations of tissue repair and longevity.
Peptide Therapy Research Context
Within peptide therapy research, vilon is classified alongside other short peptide bioregulators such as epithalon and thymalin. Its value lies in its simplicity and its demonstrated effects on chromatin regulation at the molecular level. Research findings from Georgian Med News and Bull Exp Biol Med suggest that vilon’s mechanisms may be relevant to multiple biological systems — from immune regulation to neurological and oncological research contexts.
The compound is not approved for medical use in humans and all information on this page refers exclusively to its use in laboratory research settings. Researchers exploring vilon should reference primary literature, including publications by Khavinson VKh and Lezhava T, for detailed experimental protocols and observed outcomes.
Research Findings and Current Scientific Status
Current research findings for vilon remain primarily in the preclinical phase, with studies conducted in mice, rats, and human cell cultures. The peptide has been extensively studied for its effects on gene expression, immune balance, and healthy aging markers. Key research suggests that vilon may:
- Induce decondensation of facultative heterochromatin in aged cultured lymphocytes
- Support immune cell proliferation and T cell differentiation in thymic cell cultures
- Modulate chromatin structures to restore transcriptionally active states in aging cells
- Reduce early neoplastic changes in gastrointestinal tract tissues in experimental models
- Promote tissue repair and cellular integrity in critical organ systems
- Extend lifespan and reduce spontaneous tumor incidence in laboratory models
All research findings are derived from laboratory models and cell culture systems. Translation to human biological systems requires further investigation.
Potential Side Effects and Safety Considerations
As a research compound, potential side effects of vilon have not been comprehensively characterized in human studies. Animal studies and in vitro research have not reported significant adverse events at doses used in laboratory settings. The peptide appears to have a favorable safety profile in experimental models — consistent with the behavior of other short peptides in this class.
Researchers should note that all use of vilon must be strictly for research purposes only. This compound is not intended for human use, consumption, or administration. Research protocols should comply with applicable ethical guidelines and institutional requirements.
Research Use Only
All information on this page is intended strictly for scientific research purposes. Vilon peptide is a research chemical available exclusively for laboratory and preclinical investigation. Nothing on this page constitutes medical advice, dosing guidance, or a recommendation for human use. Researchers should consult qualified laboratory professionals and follow all regulatory compliance requirements when handling research compounds.